Endurance Wealth Management, Inc. Logic Bio Therapeutics, Inc. Transaction History

Endurance Wealth Management, Inc.

  • $731 Million
  • Q2 2023

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 15, 2021
BUY
$5.29 - $9.1 $7,935 - $13,650
1,500 New
1,500 $11,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Endurance Wealth Management, Inc. Portfolio

Follow Endurance Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email